Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Revenue    
Total revenue $ 4,765 $ 4,333
Cost of revenues 2,532 1,798
Gross margin 2,233 2,535
Operating expenses    
General and administrative 3,132 2,246
Sales and marketing 335 221
Depreciation and amortization 285 259
Total operating expenses 3,752 2,726
Loss from operations (1,519) (191)
Other income/(expenses)    
Loss from equity method investments (23) (107)
Other income (expense), net (3) 57
Accretion expense (95) (185)
Interest expense, net (18) (53)
Total other expense (139) (288)
Loss before income taxes (1,658) (479)
Income tax benefit 427 65
Net loss $ (1,231) $ (414)
Loss per common share    
Basic $ (0.02) $ (0.01)
Diluted $ (0.02) $ (0.01)
Weighted average number of common shares used in per share calculation - basic 56,537,711 34,795,313
Weighted average number of common shares used in per share calculation - diluted 56,537,711 34,795,313
Patient service fees, net    
Revenue    
Total revenue $ 2,950 $ 2,346
Hospital, management and other    
Revenue    
Total revenue $ 1,815 $ 1,987